- Home
- BMRA vs BFRI Comparison
BMRA vs BFRI Comparison
Compare BMRA & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRA
- BFRI
- Stock Information
- Founded
- BMRA 1971
- BFRI 1997
- Country
- BMRA United States
- BFRI United States
- Employees
- BMRA N/A
- BFRI N/A
- Industry
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- BFRI Biotechnology: Pharmaceutical Preparations
- Sector
- BMRA Health Care
- BFRI Health Care
- Exchange
- BMRA Nasdaq
- BFRI Nasdaq
- Market Cap
- BMRA 7.6M
- BFRI 7.9M
- IPO Year
- BMRA N/A
- BFRI 2021
- Fundamental
- Price
- BMRA $3.47
- BFRI $0.93
- Analyst Decision
- BMRA
- BFRI Strong Buy
- Analyst Count
- BMRA 0
- BFRI 1
- Target Price
- BMRA N/A
- BFRI $2.75
- AVG Volume (30 Days)
- BMRA 2.1M
- BFRI 60.4K
- Earning Date
- BMRA 10-14-2025
- BFRI 08-13-2025
- Dividend Yield
- BMRA N/A
- BFRI N/A
- EPS Growth
- BMRA N/A
- BFRI N/A
- EPS
- BMRA N/A
- BFRI N/A
- Revenue
- BMRA $5,678,000.00
- BFRI $39,188,000.00
- Revenue This Year
- BMRA N/A
- BFRI $11.75
- Revenue Next Year
- BMRA N/A
- BFRI $17.09
- P/E Ratio
- BMRA N/A
- BFRI N/A
- Revenue Growth
- BMRA 5.01
- BFRI 11.20
- 52 Week Low
- BMRA $2.08
- BFRI $0.54
- 52 Week High
- BMRA $10.16
- BFRI $2.22
- Technical
- Relative Strength Index (RSI)
- BMRA 55.33
- BFRI 51.07
- Support Level
- BMRA $2.80
- BFRI $0.84
- Resistance Level
- BMRA $3.26
- BFRI $1.01
- Average True Range (ATR)
- BMRA 0.32
- BFRI 0.08
- MACD
- BMRA 0.03
- BFRI -0.02
- Stochastic Oscillator
- BMRA 37.22
- BFRI 42.20
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.